Multi-epitopic oncomicrobial vaccine
Multi-epitopic oncomicrobial vaccine has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, May 28, 2026: “Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines”.
1 paper studies it1 findingUpdated
See all 1 papers on multi-epitopic oncomicrobial vaccine
What did studies of multi-epitopic oncomicrobial vaccine find?
1Studies of multi-epitopic oncomicrobial vaccine measured one outcome, Fragipain-fragilysin cascade.
Fragipain-fragilysin cascade
downin reviews1
1 study
Fragipain-fragilysin cascade
downin reviews1
Multi-epitopic oncomicrobial vaccine inhibits fragipain-fragilysin cascade.
“designed to permanently neutralize the fragipain-fragilysin cascade”
Reviewmulti-epitopic
Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines
Zenodo (CERN European Organization for Nuclear Research)Preprint